OBJECTIVE: To assess patient recruitment and quality of data in a randomized database study. STUDY DESIGN AND SETTING: A randomized database study was conducted in the Integrated Primary Care Information (IPCI) general practice research database. Software was built to allow for automated patient identification and recruitment, and randomization. As an application, we compared gastrointestinal tolerability in persons treated withdiclofenac and celecoxibfor osteoarthritis. The outcomes were assessed in the IPCI database. To assess accuracy of exposure and outcome, we also collected information by self-administrated patient questionnaires. For all eligible subjects, we assessed the main reason for noninclusion. Physicians were interviewed to evaluate the study and to identify the major obstacles. RESULTS:Forty-two general practice physicians collaborated with the study and 7,127 potential study subjects were identified. Among these subjects, 170 were eligible for recruitment and 20 (11.8%) were randomized. Of the eligible patients, 96 (56.5%) were not recruited because the physician was too busy or the patient was treated by another healthcare provider and 54 (31.8%) were not recruited because of exclusion criteria. CONCLUSION: Concordance between questionnaires and IPCI data and the outcome was good (kappa=0.7; SD=0.14). The physicians reported that recruitment during routine visits was too time-consuming, in particular because of the need for informed consent. Although a randomized database study is feasible, patient recruitment during routine consultations should be avoided.
RCT Entities:
OBJECTIVE: To assess patient recruitment and quality of data in a randomized database study. STUDY DESIGN AND SETTING: A randomized database study was conducted in the Integrated Primary Care Information (IPCI) general practice research database. Software was built to allow for automated patient identification and recruitment, and randomization. As an application, we compared gastrointestinal tolerability in persons treated with diclofenac and celecoxib for osteoarthritis. The outcomes were assessed in the IPCI database. To assess accuracy of exposure and outcome, we also collected information by self-administrated patient questionnaires. For all eligible subjects, we assessed the main reason for noninclusion. Physicians were interviewed to evaluate the study and to identify the major obstacles. RESULTS: Forty-two general practice physicians collaborated with the study and 7,127 potential study subjects were identified. Among these subjects, 170 were eligible for recruitment and 20 (11.8%) were randomized. Of the eligible patients, 96 (56.5%) were not recruited because the physician was too busy or the patient was treated by another healthcare provider and 54 (31.8%) were not recruited because of exclusion criteria. CONCLUSION: Concordance between questionnaires and IPCI data and the outcome was good (kappa=0.7; SD=0.14). The physicians reported that recruitment during routine visits was too time-consuming, in particular because of the need for informed consent. Although a randomized database study is feasible, patient recruitment during routine consultations should be avoided.
Authors: Alex Butler; Junghwan Lee; Yat So; Linda Busacca; Karen Marder; Henry N Ginsberg; Dianne Frederick; Ismael Castaneda; Elizabeth Guerridoi; Chunhua Weng Journal: AMIA Annu Symp Proc Date: 2021-01-25
Authors: Chunhua Weng; Paul Appelbaum; George Hripcsak; Ian Kronish; Linda Busacca; Karina W Davidson; J Thomas Bigger Journal: J Am Med Inform Assoc Date: 2012-04-29 Impact factor: 4.497
Authors: Chunhua Weng; Yu Li; Solomon Berhe; Mary Regina Boland; Junfeng Gao; Gregory W Hruby; Richard C Steinman; Carlos Lopez-Jimenez; Linda Busacca; George Hripcsak; Suzanne Bakken; J Thomas Bigger Journal: J Biomed Inform Date: 2013-05-16 Impact factor: 6.317
Authors: Kelly Claire Simon; Samuel Tideman; Laura Hillman; Rebekah Lai; Raman Jathar; Yuan Ji; Stuart Bergman-Bock; James Castle; Tiffani Franada; Thomas Freedom; Revital Marcus; Angela Mark; Steven Meyers; Susan Rubin; Irene Semenov; Chad Yucus; Anna Pham; Lisette Garduno; Monika Szela; Roberta Frigerio; Demetrius M Maraganore Journal: JAMIA Open Date: 2018-06-11
Authors: Fouzia Lghoul-Oulad Saïd; Karin Hek; Linda E Flinterman; Ron Mc Herings; Margaretha F Warlé-van Herwaarden; Sandra de Bie; Vera E Valkhoff; Jelmer Alsma; Mees Mosseveld; Ann M Vanrolleghem; Bruno Hch Stricker; Miriam Cjm Sturkenboom; Peter Agm De Smet; Patricia Mla van den Bemt Journal: Pharmacoepidemiol Drug Saf Date: 2020-10-13 Impact factor: 2.890